PrecisionOne with Intravenous Laboratory
Automated glycemic control and continuous metabolic monitoring in critical care/surgery
Key Facts
About Admetsys
Admetsys is pioneering automated clinical robotics for critical care, targeting two major challenges: precise glycemic control and early sepsis detection. Its system combines the PrecisionOne™ autonomous controller with the Intravenous Laboratory™ for continuous, blood-based biosensing, aiming to eliminate manual interventions and improve standard of care. With FDA Breakthrough Designation and CE Mark approval for PrecisionOne, the company is advancing toward commercialization with strong clinical trial data showing superior glucose control and safety compared to manual methods. Admetsys addresses significant ICU burdens including staff shortages, cost pressures, and variable patient outcomes.
View full company profile